生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Verteporfin (CL 318952) is utilized as a photosensitizer in photodynamic therapy aimed at eradicating abnormal blood vessels in the eye, particularly in conditions like age-related macular degeneration. It also functions as a YAP inhibitor, effectively disrupting YAP-TEAD interactions and inducing apoptosis in cells[1]. Additionally, Verteporfin acts as an autophagy inhibitor, specifically blocking the early stages of autophagy by preventing autophagosome formation[3]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 |
ARPE-19 | ~0.1 μg/ml | cytotoxicity assay | shows a dose-dependent toxicity | 16987905 | |
ARPE-19 | 0.01 μg/ml | Function assay | increases VEGF and reduces PEDF expression | 16987905 | |
ARPE-19 | 0.5 µg/ml | cytotoxicity assay | decreases viability by 55.5% | 23441114 |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00211484 | Age-Related Macular Degenerati... 展开 >>ons. Subfoveal Neovascularization. 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Manhattan Eye, Ear & Throat Hospital New York, New York, United States, 10021 收起 << |
NCT02587767 | Acute Central Serous Chorioret... 展开 >>inopathy 收起 << | Not Applicable | Active, not recruiting | December 2018 | China, Guangdong ... 展开 >> Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 收起 << |
NCT02072408 | Polypoidal Choroidal Vasculopa... 展开 >>thy Without Active Polyp 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyunggi-do, Korea, Republic of Konyang University Kim's Eye Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.39mL 0.28mL 0.14mL |
6.96mL 1.39mL 0.70mL |
13.91mL 2.78mL 1.39mL |
参考文献 |
---|